Relx confirms guidance after 'strong' start to the year
reiterated its full-year outlook on Thursday, after the analytics provider said the year had got off to a "strong" start.
The global firm, which provides information-based analytics and decision tools to professionals businesses, said underlying revenues had grown in all four of its divisions.
In risk, which accounts for 34% of group sales, strong revenue growth had been driven largely by financial crime compliance and by digital fraud and identity.
In its scientific, technical and medical unit, Relx's second-biggest division, the jump in revenues was attributed to "the evolution of the business mix".
Relx said: "The full-year outlook is unchanged.
"We continue to see positive momentum across the group, and we expect another year of strong underlying growth in revenue and adjusted operating profit, as well as strong growth in adjusted earnings per share on a constant currency basis."
As at 0830 BST, the blue chip's London-listed shares were up 1% at 3,965p. The company, which employs around 36,000 people across more than 180 countries, is also listed in Amsterdam and New York.
Relx, formerly known as Reed Elsevier, was updating investors ahead of its annual general meeting. Its year end is 31 December 2025.
Disclaimer & Declaration of Interest
The information, investment views and recommendations in this article are provided for general information purposes only. Nothing in this article should be construed as a solicitation to buy or sell any financial product relating to any companies under discussion or to engage in or refrain from doing so or engaging in any other transaction. Any opinions or comments are made to the best of the knowledge and belief of the writer but no responsibility is accepted for actions based on such opinions or comments. Vox Markets may receive payment from companies mentioned for enhanced profiling or publication presence. The writer may or may not hold investments in the companies under discussion.